nuTCRacker: Predicting the Recognition of HLA‐I–Peptide Complexes by αβTCRs for Unseen Peptides
The ability to predict which antigenic peptide(s) the αβTCR of a given CD8<sup>+</sup> T-cell clone can recognise would represent a quantum leap in the understanding of T-cell repertoire selection and development of targeted cell-mediated immunotherapies. Current methods fail to make accurate predictions for antigenic peptides not present in the training dataset. Here, we propose a novel deep learning method called nuTCRacker that makes accurate predictions for a subset of unseen peptides, with an AUC > 0.7 for around a third of peptides evaluated using a large dataset compiled from curated public resources. An additional evaluation was undertaken using a small cellula-validated dataset of αβTCR peptides associated with cancer. Our analysis suggests that it is possible to make useful predictions for an unseen peptide provided the training dataset contains: many samples with the same HLA class I molecule as that bound to the peptide; at least one peptide that is similar to the target peptide; and a small number of αβTCRs that are similar to those bound to the unseen peptide of interest.
Authors
- Justin Barton (ORCID: https://orcid.org/0000-0002-1244-9484)
- Meghna Phanichkrivalkosil
- Adrian J. Shepherd (ORCID: https://orcid.org/0000-0003-0194-8613)
- Michele Mishto (ORCID: https://orcid.org/0000-0003-3042-2792)
- Trupti Gore
Institutions
- King's College London (GB)
- The Francis Crick Institute (GB)
- Birkbeck, University of London (GB)
Publication Details
- Journal
- European Journal of Immunology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1002/eji.202451607
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Francis Crick Institute
- UK Research and Innovation
- Cancer Research UK
- Leids Universitair Medisch Centrum
- Blood Cancer UK
- Directorate for Biological Sciences
- Medical Research Council